sj-pptx-2-taj-10.1177_20406223231223286 – Supplemental material for The totality of evidence approach in the development of AVT02 (adalimumab), a biosimilar to Humira
Version 2 2024-03-26, 08:06Version 2 2024-03-26, 08:06
Version 1 2024-01-20, 13:08Version 1 2024-01-20, 13:08
presentation
posted on 2024-03-26, 08:06authored byJoseph E. McClellan, Sesselja Ómarsdóttir, Nivedita Roy, Verena Berger, Cecilia Michel, Fausto Berti
Supplemental material, sj-pptx-2-taj-10.1177_20406223231223286 for The totality of evidence approach in the development of AVT02 (adalimumab), a biosimilar to Humira by Joseph E. McClellan, Sesselja Ómarsdóttir, Nivedita Roy, Verena Berger, Cecilia Michel and Fausto Berti in Therapeutic Advances in Chronic Disease